Banks - Regional
Compare Stocks
4 / 10Stock Comparison
FRST vs NKSH vs NBTB vs CARE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
FRST vs NKSH vs NBTB vs CARE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $360M | $240M | $2.35B | $580M |
| Revenue (TTM) | $313M | $85M | $867M | $255M |
| Net Income (TTM) | $61M | $16M | $169M | $31M |
| Gross Margin | 67.6% | 65.1% | 72.1% | 61.7% |
| Operating Margin | 23.2% | 22.5% | 25.3% | 15.7% |
| Forward P/E | 9.1x | 11.7x | 10.8x | 4.8x |
| Total Debt | $262M | $2M | $327M | $179M |
| Cash & Equiv. | $144M | $8M | $185M | $105M |
FRST vs NKSH vs NBTB vs CARE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Primis Financial Co… (FRST) | 100 | 145.0 | +45.0% |
| National Bankshares… (NKSH) | 100 | 122.4 | +22.4% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FRST vs NKSH vs NBTB vs CARE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FRST carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 23.0%, EPS growth 477.3%
- PEG 0.43 vs NBTB's 1.53
- 23.0% NII/revenue growth vs CARE's 6.2%
- Lower P/E (9.1x vs 11.7x), PEG 0.43 vs 145.48
NKSH is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 0.76, yield 4.0%
- Lower volatility, beta 0.76, Low D/E 1.1%, current ratio 1203.84x
- Beta 0.76, yield 4.0%, current ratio 1203.84x
- Efficiency ratio 0.4% vs NBTB's 0.5% (lower = leaner)
NBTB is the clearest fit if your priority is bank quality.
- NIM 3.1% vs NKSH's 2.5%
CARE is the clearest fit if your priority is long-term compounding.
- 112.9% 10Y total return vs NBTB's 102.2%
- Beta 0.56 vs NBTB's 0.89
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.0% NII/revenue growth vs CARE's 6.2% | |
| Value | Lower P/E (9.1x vs 11.7x), PEG 0.43 vs 145.48 | |
| Quality / Margins | Efficiency ratio 0.4% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs NBTB's 0.89 | |
| Dividends | 4.0% yield, 1-year raise streak, vs NBTB's 3.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +72.1% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs NBTB's 0.5% |
FRST vs NKSH vs NBTB vs CARE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
FRST vs NKSH vs NBTB vs CARE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 1 of 6 categories
FRST leads 1 • CARE leads 1 • NKSH leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 10.2x NKSH's $85M. FRST is the more profitable business, keeping 19.7% of every revenue dollar as net income compared to CARE's 12.3%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $313M | $85M | $867M | $255M |
| EBITDAEarnings before interest/tax | $79M | $20M | $241M | $46M |
| Net IncomeAfter-tax profit | $61M | $16M | $169M | $31M |
| Free Cash FlowCash after capex | $9M | $17M | $225M | $30M |
| Gross MarginGross profit ÷ Revenue | +67.6% | +65.1% | +72.1% | +61.7% |
| Operating MarginEBIT ÷ Revenue | +23.2% | +22.5% | +25.3% | +15.7% |
| Net MarginNet income ÷ Revenue | +19.7% | +18.6% | +19.5% | +12.3% |
| FCF MarginFCF ÷ Revenue | +2.9% | +17.8% | +25.2% | +12.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +2.3% | +91.7% | +39.5% | +8.3% |
Valuation Metrics
FRST leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 5.9x trailing earnings, FRST trades at a 69% valuation discount to CARE's 18.7x P/E. Adjusting for growth (PEG ratio), FRST offers better value at 0.28x vs NKSH's 145.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $360M | $240M | $2.4B | $580M |
| Enterprise ValueMkt cap + debt − cash | $479M | $234M | $2.5B | $654M |
| Trailing P/EPrice ÷ TTM EPS | 5.86x | 15.14x | 13.53x | 18.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.10x | 11.71x | 10.80x | 4.77x |
| PEG RatioP/E ÷ EPS growth rate | 0.28x | 145.48x | 1.92x | — |
| EV / EBITDAEnterprise value multiple | 6.60x | 12.20x | 10.35x | 16.34x |
| Price / SalesMarket cap ÷ Revenue | 1.15x | 2.81x | 2.71x | 2.28x |
| Price / BookPrice ÷ Book value/share | 0.85x | 1.30x | 1.21x | 1.40x |
| Price / FCFMarket cap ÷ FCF | 39.89x | 15.85x | 10.75x | 18.25x |
Profitability & Efficiency
Evenly matched — FRST and NKSH each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
FRST delivers a 15.8% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $8 for CARE. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to FRST's 0.62x. On the Piotroski fundamental quality scale (0–9), NKSH scores 8/9 vs FRST's 6/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.8% | +9.0% | +9.5% | +7.6% |
| ROA (TTM)Return on assets | +1.6% | +0.9% | +1.1% | +0.7% |
| ROICReturn on invested capital | +9.2% | +8.4% | +7.9% | +5.7% |
| ROCEReturn on capital employed | +6.1% | +1.9% | +2.4% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.62x | 0.01x | 0.17x | 0.43x |
| Net DebtTotal debt minus cash | $119M | -$6M | $142M | $73M |
| Cash & Equiv.Liquid assets | $144M | $8M | $185M | $105M |
| Total DebtShort + long-term debt | $262M | $2M | $327M | $179M |
| Interest CoverageEBIT ÷ Interest expense | 0.82x | 0.64x | 1.05x | 0.39x |
Total Returns (Dividends Reinvested)
Evenly matched — FRST and CARE each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $11,317 for FRST. Over the past 12 months, FRST leads with a +72.1% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors FRST at 29.3% vs NBTB's 15.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.6% | +14.2% | +9.3% | +34.8% |
| 1-Year ReturnPast 12 months | +72.1% | +49.7% | +9.0% | +69.0% |
| 3-Year ReturnCumulative with dividends | +116.0% | +55.1% | +54.1% | +94.7% |
| 5-Year ReturnCumulative with dividends | +13.2% | +31.9% | +29.9% | +87.2% |
| 10-Year ReturnCumulative with dividends | +52.1% | +51.3% | +102.2% | +112.9% |
| CAGR (3Y)Annualised 3-year return | +29.3% | +15.7% | +15.5% | +24.9% |
Risk & Volatility
CARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than NBTB's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 98.5% from its 52-week high vs NKSH's 94.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | 0.76x | 0.89x | 0.56x |
| 52-Week HighHighest price in past year | $14.97 | $40.00 | $46.92 | $26.58 |
| 52-Week LowLowest price in past year | $8.69 | $24.74 | $39.20 | $15.37 |
| % of 52W HighCurrent price vs 52-week peak | +97.5% | +94.3% | +96.1% | +98.5% |
| RSI (14)Momentum oscillator 0–100 | 64.9 | 51.1 | 57.3 | 75.4 |
| Avg Volume (50D)Average daily shares traded | 191K | 50K | 236K | 276K |
Analyst Outlook
Evenly matched — NKSH and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FRST as "Buy", NKSH as "Buy", NBTB as "Hold", CARE as "Buy". Consensus price targets imply 3.1% upside for CARE (target: $27) vs -4.0% for FRST (target: $14). For income investors, NKSH offers the higher dividend yield at 4.01% vs FRST's 2.74%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $14.00 | — | $46.00 | $27.00 |
| # AnalystsCovering analysts | 2 | 4 | 10 | 4 |
| Dividend YieldAnnual dividend ÷ price | +2.7% | +4.0% | +3.2% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 12 | 0 |
| Dividend / ShareAnnual DPS | $0.40 | $1.51 | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +0.4% | +3.4% |
NBTB leads in 1 of 6 categories (Income & Cash Flow). FRST leads in 1 (Valuation Metrics). 3 tied.
FRST vs NKSH vs NBTB vs CARE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FRST or NKSH or NBTB or CARE a better buy right now?
For growth investors, Primis Financial Corp.
(FRST) is the stronger pick with 23. 0% revenue growth year-over-year, versus 6. 2% for Carter Bankshares, Inc. (CARE). Primis Financial Corp. (FRST) offers the better valuation at 5. 9x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Primis Financial Corp. (FRST) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FRST or NKSH or NBTB or CARE?
On trailing P/E, Primis Financial Corp.
(FRST) is the cheapest at 5. 9x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Primis Financial Corp. wins at 0. 43x versus National Bankshares, Inc. 's 145. 48x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FRST or NKSH or NBTB or CARE?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to +13. 2% for Primis Financial Corp. (FRST). Over 10 years, the gap is even starker: CARE returned +112. 9% versus NKSH's +51. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FRST or NKSH or NBTB or CARE?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus NBT Bancorp Inc. 's 0. 89β — meaning NBTB is approximately 58% more volatile than CARE relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 62% for Primis Financial Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — FRST or NKSH or NBTB or CARE?
By revenue growth (latest reported year), Primis Financial Corp.
(FRST) is pulling ahead at 23. 0% versus 6. 2% for Carter Bankshares, Inc. (CARE). On earnings-per-share growth, the picture is similar: Primis Financial Corp. grew EPS 477. 3% year-over-year, compared to 12. 5% for NBT Bancorp Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FRST or NKSH or NBTB or CARE?
Primis Financial Corp.
(FRST) is the more profitable company, earning 19. 7% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 19. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 15. 7% for CARE. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FRST or NKSH or NBTB or CARE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Primis Financial Corp. (FRST) is the more undervalued stock at a PEG of 0. 43x versus National Bankshares, Inc. 's 145. 48x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 7x for National Bankshares, Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 1% to $27. 00.
08Which pays a better dividend — FRST or NKSH or NBTB or CARE?
In this comparison, NKSH (4.
0% yield), NBTB (3. 2% yield), FRST (2. 7% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is FRST or NKSH or NBTB or CARE better for a retirement portfolio?
For long-horizon retirement investors, National Bankshares, Inc.
(NKSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76), 4. 0% yield). Both have compounded well over 10 years (NKSH: +51. 3%, CARE: +112. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FRST and NKSH and NBTB and CARE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FRST is a small-cap high-growth stock; NKSH is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock. FRST, NKSH, NBTB pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.